Document is current
Any future updates will be listed below
-
Authors
Le Pelletier, Laura
Ngono Ayissi, Kenza
Gorwood, Jennifer
Capel, Emilie
Morichon, Romain
Mantecon, Matthieu
Auclair, Martine
Alili, Rohia
Katlama, Christine
Cuzin, Lise
Atlan, Michael
Beaupère, Carine
Poitou, Christine
Boccara, Franck
Fève, Bruno
Capeau, Jacqueline
Lagathu, Claire
Béréziat, Véronique
-
Funding
Funding for this research was provided by:
Sorbonne Université
Sidaction (FJC-13006)
RHU CARMMA (RHU-ANR-15-RHUS-0003)
RHU CARMMA (RHU-ANR-15-RHUS-0003)
Agence Nationale de Recherches sur le Sida et les Hépatites Virales (NCT01420523)
Agence Nationale de Recherches sur le Sida et les Hépatites Virales (NCT00944541)
Agence Nationale de Recherches sur le Sida et les Hépatites Virales (NCT01899196)
Institut National de la Santé et de la Recherche Médicale
Fondation pour la Recherche Médicale (EQU201903007868)
- License Information
-
More Information
Article History
Received: 18 March 2025
Accepted: 5 June 2025
First Online: 18 July 2025
Declarations
:
: The ROCnRAL ANRS-157 was a single-arm study designed to evaluate a switch to a maraviroc plus raltegravir regimen in virologically suppressed HIV-1-infected patients. The Institutional Review Board of Pitie-Salpétrière Hospital approved the study protocol (ClinicalTrials.gov: NCT01420523). All patients provided written informed consent. The ANRS145 Marimuno study was a multicenter, noncomparative, prospective 36-week trial conducted in 16 “Agence nationale de recherche sur le sida et les hépatites” (ANRS) sites in France. The ethics committee in Toulouse, France approved the protocol (EudraCT: 2009-011171-76). All patients gave written informed consent. The PIECVIH ANRS EP52 study was a cross-sectional, study comparing the inflammatory state of epicardial adipose tissue (EAT) between people living with HIV and controls undergoing coronary artery bypass graft. The Institutional Review Board of Saint-Antoine Hospital approved the study protocol (ClinicalTrials.gov: NCT01899196). All patients provided written informed consent. Human adipose-derived stromal cells (ASCs). Adipose stromal cells were isolated from nine donors. All donors provided their written, informed consent to the use of their tissue specimens for research purposes. The study was performed in compliance with the principles of the Declaration of Helsinki and was approved by an institutional review board. The study was approved by the French regulatory authorities (CODECOH DC2023-5617).
: J.C. reports personal fees for lectures from ViiV Healthcare, Gilead and MSD outside the sub-mitted work. B.F. reports research grants from MSD, and personal fees for lectures for MSD, Amgen, Sanofi, NovoNordisk, and Lilly outside the submitted work. C.L. has received personal fees from MSD, outside the submitted work. F.B. reports research grants from Amgen; lecture fees from Gilead, ViiV Healthcare, Amgen, Sanofi, MSD, NovoNordisk, Novartis and Servier outside the submitted work. C. K. has received travel grants, consultancy fees, and honoraria or study grants from Gilead, Merck, Janssen, and ViiV Healthcare outside the submitted work. L.L., K.N.A., J.G., R.M., M.M., M.A., R.A., L.C., M.A., C.B., C.P., E.C. and V.B. declare no conflicts of interest.
